chr6-31948623-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001710.6(CFB):c.1036+111A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.684 in 1,558,018 control chromosomes in the GnomAD database, including 370,930 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.73 ( 40872 hom., cov: 31)
Exomes 𝑓: 0.68 ( 330058 hom. )
Consequence
CFB
NM_001710.6 intron
NM_001710.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00600
Publications
72 publications found
Genes affected
CFB (HGNC:1037): (complement factor B) This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2. [provided by RefSeq, Jul 2008]
CFB Gene-Disease associations (from GenCC):
- atypical hemolytic-uremic syndrome with B factor anomalyInheritance: Unknown, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- complement factor b deficiencyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-31948623-A-G is Benign according to our data. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-31948623-A-G is described in CliVar as Benign. Clinvar id is 1285918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.84 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFB | NM_001710.6 | c.1036+111A>G | intron_variant | Intron 7 of 17 | ENST00000425368.7 | NP_001701.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.728 AC: 110561AN: 151928Hom.: 40834 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
110561
AN:
151928
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.679 AC: 955050AN: 1405972Hom.: 330058 AF XY: 0.688 AC XY: 482739AN XY: 701636 show subpopulations
GnomAD4 exome
AF:
AC:
955050
AN:
1405972
Hom.:
AF XY:
AC XY:
482739
AN XY:
701636
show subpopulations
African (AFR)
AF:
AC:
27010
AN:
32598
American (AMR)
AF:
AC:
31010
AN:
43710
Ashkenazi Jewish (ASJ)
AF:
AC:
22868
AN:
25754
East Asian (EAS)
AF:
AC:
25418
AN:
39388
South Asian (SAS)
AF:
AC:
74377
AN:
84600
European-Finnish (FIN)
AF:
AC:
31086
AN:
45412
Middle Eastern (MID)
AF:
AC:
4821
AN:
5384
European-Non Finnish (NFE)
AF:
AC:
697928
AN:
1070478
Other (OTH)
AF:
AC:
40532
AN:
58648
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
16174
32348
48523
64697
80871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18042
36084
54126
72168
90210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.728 AC: 110653AN: 152046Hom.: 40872 Cov.: 31 AF XY: 0.731 AC XY: 54340AN XY: 74302 show subpopulations
GnomAD4 genome
AF:
AC:
110653
AN:
152046
Hom.:
Cov.:
31
AF XY:
AC XY:
54340
AN XY:
74302
show subpopulations
African (AFR)
AF:
AC:
33827
AN:
41476
American (AMR)
AF:
AC:
10930
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
3083
AN:
3472
East Asian (EAS)
AF:
AC:
3035
AN:
5156
South Asian (SAS)
AF:
AC:
4152
AN:
4816
European-Finnish (FIN)
AF:
AC:
7416
AN:
10564
Middle Eastern (MID)
AF:
AC:
266
AN:
294
European-Non Finnish (NFE)
AF:
AC:
45619
AN:
67968
Other (OTH)
AF:
AC:
1640
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1493
2985
4478
5970
7463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2441
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.